Company Filing History:
Years Active: 2010-2011
Title: Berta Kotar-Jordan: An Innovator in Pharmaceutical Patents
Introduction
Berta Kotar-Jordan is a notable inventor based in Kostanjevica na Krki, Slovenia. With a passion for pharmaceutical innovations, she holds two significant patents that contribute to advancements in drug formulation and preparation.
Latest Patents
Berta's latest patents reflect her expertise in the pharmaceutical field. The first patent involves the "Isopropanol water solvate of olanzapine," which introduces a novel and well-defined solvate form of olanzapine consisting of two molecules of water and one molecule of isopropanol per two molecules of olanzapine. This innovative formulation can be transformed into other forms of olanzapine, particularly form (I), and outlines the processes for preparing this specific form.
Her second patent, titled "Process for preparing lansoprazole," describes the method for synthesizing lansoprazole and highlights the chemical with a specific surface area, as well as a pharmaceutical composition that includes lansoprazole.
Career Highlights
Berta Kotar-Jordan is a key figure at Krka, Tovarna Zdravil, D.d., a company known for its commitment to research-driven pharmaceutical solutions. Her work focuses on maximizing the effectiveness of medications through innovative processes and formulations. Berta's contributions have positioned her as an influential member of the pharmaceutical community.
Collaborations
Collaboration is essential in the realm of innovation, and Berta works alongside esteemed colleagues such as Franc Vrecer and Mojca Segula Zakelj. Together, they contribute to an environment that fosters creativity and expedites the development of groundbreaking pharmaceutical solutions.
Conclusion
Berta Kotar-Jordan exemplifies the spirit of innovation in the pharmaceutical industry. With her impressive array of patents and collaborative efforts within Krka, she continues to make significant strides in advancing health solutions. Her work not only benefits the pharmaceutical sector but also enhances the lives of patients worldwide.